SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: VLAD who wrote (11010)7/9/1998 6:48:00 PM
From: Paul Kelly  Read Replies (2) of 23519
 
I come up with similar numbers.
They justify analyst expectations of $1/sh going forward.
Not blockbuster numbers, but not cause for hanging crepe either.
The company has a niche market that has several key features that potential marketing partners are finding attractive: (1) HMO/insurance companies will reimburse muse but not viagra because of safety record (2)potentially more effective than viagra in certain patient sets (3) less of a potential liability headache.
If it drops to 6 its a screaming buy (unless you have the patience of a 3 year old). And, threadmembers,dont worry so much about its price on instanet or what covered calls will cost.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News